Acarbose treatment enhances mid-regional pro-atrial natriuretic peptide concentrations in non-diabetic individuals: further evidence for a common cardiometabolic pathway?
- 20 September 2012
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 55 (12) , 3392-3395
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Insulin Up-Regulates Natriuretic Peptide Clearance Receptor Expression in the Subcutaneous Fat Depot in Obese Subjects: A Missing Link between CVD Risk and Obesity?The Journal of Clinical Endocrinology & Metabolism, 2012
- B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway?Diabetologia, 2012
- B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy menDiabetologia, 2011
- Effects of Acarbose Treatment on Markers of Insulin Sensitivity and Systemic InflammationDiabetes Technology & Therapeutics, 2011
- Impact of Obesity on Plasma Natriuretic Peptide LevelsCirculation, 2004
- Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studiesEuropean Heart Journal, 2004
- Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose ToleranceJAMA, 2003